Publications

By Zora Scientists

 

2010

  


Ekroos K, Jänis M, Tarasov K, Hurme R, Laaksonen R. Lipidomics: A Tool for Studies of Atherosclerosis Curr Atheroscler Rep. 2010 Apr 28. [Epub ahead of print]

 

2009

 


Ejsing CS, Sampaio JL, Surendranath V, Duchoslav E, Ekroos K, Klemm RW, Simons K, Shevchenko A. Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry Proc Natl Acad Sci USA. 2009 Jan 27.


Ståhlman M, Ejsing CS, Tarasov K, Perman J, Borén J, Ekroos K.
High-Throughput Shotgun Lipidomics by Quadrupole Time-of-Flight Mass Spectrometry Journal of Chromatography B. 2009 

Sergent O, Ekroos K, Lefeuvre-Orfila L, Rissel M, Forsberg G-B, Oscarsson J, Andersson TB,Lagadic-Gossmann D. Ximelagatran increases membrane fluidity and changes membrane lipid
composition in primary human hepatocytes
Toxicology in Vitro, 2009 Jul 16.

 

2008

 


Ekroos, K. Unraveling glycerophospholipidomes by lipidomics, in “Biomarker methods in drug discovery and development, Methods in pharmacology and toxicology”
Humana Press, 2008.

Tarassov K, Messier V, Landry CR, Radinovic S, Molina MM, Shames I, Malitskaya Y, Vogel J, Bussey H, Michnick SW. An in Vivo Map of the Yeast Protein Interactome
Science (2008); 320: 1465-1470.

Orešič M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T. et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
JEM (2008) 205, No. 13, 2975-2984.

Jänis MT, Laaksonen R, Orešič M.  Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs
Expert Opin. Drug Metab. Toxicol. (2008) 4(6):665-680.

 

2007

 


Lelliott CJ, Ljungberg A, Ahnmark A, William-Olsson L, Ekroos K, Elmgren A, Arnerup G, Shoulders CC, Oscarsson J, Lindén D. Hepatic PGC-1β over-expression induces combined hyperlipidemia and modulates the response to PPARα Activation.
Arterioscler Thromb Vasc Biol. (2007) 27, 2707-2713.

Schick B, Laaksonen R, Frohlich J, Päivä H, Lehtimäki T, Humphries KH, Côté H. Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin
Clin Pharmacol Ther (2007);81(5):650-3.

     

  

2006

 


Lindén D, William-Olsson L, Ahnmark A, Ekroos K, Hallberg C, Peilot-Sjögren H, Becker B, Svensson L, Clapham JC, Oscarsson J, Schreyer S. Liver directed overexpression of mithocondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triglyceride secretion and reduced fatty acid oxidation
FASEB J. 20(3):434-43 (2006).

Laaksonen R, Katajamaa M, Päivä H, Sysi-Aho M, Saarinen L, Junni P, Lütjohann D, Smet J, Van Coster R, Seppänen-Laakso T, Lehtimäki T,  Soini J, Orešič M. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin induced changes in muscle
PLoS ONE 1(1): e97 (2006).

Eising CS, Duchoslav E, Sampaio J, Simons K, Bonner R, Thiele C, Ekroos K, Shevchenko A. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning
Anal Chem. (2006) Sep 1;78(17):6202-14.

Campbell-Valois FX, Tarassov K, Michnick SW. Massive sequence perturbation of the Raf ras binding domain reveals relationships between sequence conservation, secondary structure propensity, hydrophobic core organization and stability
J Mol Biol. 8;362(1):151-71(2006).

 

2005

 


Kuerschner L, Ejsing SC, Ekroos K, Shevchenko A, Anderson KI, Thiele C. Polyene-lipids: A new tool to image lipids Nature Methods (2005); 2, 39 – 45.

Campbell-Valois FX, Tarassov K, Michnick SW. Massive sequence perturbation of a small protein Proc Natl Acad Sci USA. (2005);102(42):14988-93.

Tarassov K, Michnick SW. iVici: Interrelational Visualization and Correlation Interface Genome Biol. 2005;6(13):R115. Epub 2005 Dec 30.

 

 

ARCHIVE